-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Iovance Biotherapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2020 to Q3 2024.
- Iovance Biotherapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.28 USD/shares, a 39.1% increase year-over-year.
- Iovance Biotherapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.5 USD/shares, a 27.9% increase year-over-year.
- Iovance Biotherapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.89 USD/shares, a 24.1% increase from 2022.
- Iovance Biotherapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.49 USD/shares, a 11.7% decline from 2021.
- Iovance Biotherapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -2.23 USD/shares, a 18.6% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)